Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents about 85% of the reported cases of lung cancer. Acquired resistance to targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, is not uncommon. It is thus vital to explore novel strategies to rest...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Mol Sci
Главные авторы: Sin, Thomas K., Wang, Fengfeng, Meng, Fei, Wong, S. C. Cesar, Cho, William C. S., Siu, Parco M., Chan, Lawrence W. C., Yung, Benjamin Y. M.
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2016
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4783968/
https://ncbi.nlm.nih.gov/pubmed/26891293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17020237
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы